Company Overview:
The Company has developed PGMEngine™, a Windows/UNIX based software product that meets the strict 21 CFR Part 11 requirements of FDA and other global regulatory agencies. This robust Enterprise-class software also can be fully integrated with the clients existing infrastructure as well. We aim to become a globally recognized brand name, capitalizing on the sustained interest in the Pharmaceutical industry.
Off-Shore Partners:
PGMEngine™’s experienced, English-speaking resource partners in Shanghai China, provide added time zone coverage, accelerated ramp-up and strong, cost effective execution for speeding up FDA submissions. Cost advantages are the single most important factor responsible for the strong growth of PGMEngine™. As costs of drug development continue to rise, and drug makers come under increasing pressure to lower drug development expenditures, PGMEngine™ has emerged as a means to solve this problem. Our off-shore solution is a proven strategy for providing time and cost efficient solutions.
Technology:
Automatically generated source code so that the company could reuse the same SAS highly sophisticated programs over and over again for different purposes. In terms of similarity, there are no other systems currently in the market.